How many new drugs were detected in Europe over the last year? What are the latest trends in drug production and trafficking? What substances are causing the most concern today? Find out more when the EU drugs agency (EMCDDA) launches its European Drug Report 2023: Trends and Developments in a press conference in Brussels on 16 June.
Based on data from 29 countries (EU 27, Türkiye and Norway), the report delivers the latest overview of the drug situation in Europe, exploring long-term trends and emerging threats. The comprehensive analysis covers drug use and supply as well as drug-related harms and responses to them.
The depth and scope of the analysis has been considerably expanded this year, with a wider range of topics covered and in greater detail. For the first time, the report is delivered in a new modular digital-first format, offering innovative ways to access and interact with the content. The resource is designed to be read across a range of devices (PCs, mobiles, tablets) and will be available in 25 EU languages.
Over 100 interactive graphics complement the analysis, while interactive dashboards allow users to visualise data and trends at European and national level. Data journalists and researchers will be able to access the underlying data for easier sharing and re-use. Accompanying the report is the 2023 Statistical Bulletin containing national datasets.
Press conference
Date: 16 June 2023 at 12.00 (Lisbon), 13.00 CET (Brussels).
Venue: European Commission, Berlaymont (VIP corner). The event will be live streamed on Europe by Satellite.
Speakers:
- Ylva Johansson, European Commissioner for Home Affairs
- Alexis Goosdeel, EMCDDA Director
Embargoed report and interviews: press@emcdda.europa.eu
Further details: www.emcdda.europa.eu/edr2023
Teaser video: https://www.youtube.com/watch?v=h3dOuSv8N70
